Clinical Outcome with Oral Linezolid and Rifampin Following Recurrent Methicillin-Resistant Staphylococcus aureus Bacteremia Despite Prolonged Vancomycin Treatment
Drug-resistant Gram-positive bacteria, especially Staphylococcus aureus, are emerging as the predominant organisms involved in both nosocomial and community-acquired infections. Since the 1980s, vancomycin has been the first-line antibiotic used to treat methicillin-resistant S aureus. However, alle...
Saved in:
Main Authors: | Jon-David Schwalm, Philippe El-Helou, Christine H Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2004-01-01
|
Series: | Canadian Journal of Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/2004/768765 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Vitro Activity of Iclaprim against Methicillin-Resistant Staphylococcus aureus Nonsusceptible to Daptomycin, Linezolid, or Vancomycin: A Pilot Study
by: David B. Huang, et al.
Published: (2017-01-01) -
Methicillin Resistant Staphylococcus aureus Prostatic Abscess with Bacteremia
by: Daniel J. Lachant, et al.
Published: (2013-01-01) -
Cost Comparison of Linezolid Versus Vancomycin for Treatment of Complicated Skin and Skin-Structure Infection Caused by Methicillin-Resistant Staphylococcus aureus in Quebec
by: Martine Pettigrew, et al.
Published: (2012-01-01) -
Data Mining Models in Prediction of Vancomycin-Intermediate <i>Staphylococcus aureus</i> in Methicillin-Resistant <i>S. aureus</i> (MRSA) Bacteremia Patients in a Clinical Care Setting
by: Wei-Chuan Chen, et al.
Published: (2025-01-01) -
Usefulness of Previous Methicillin-resistant Staphylococcus aureus Screening Results in Guiding Empirical Therapy for S Aureus Bacteremia
by: Anthony D Bai, et al.
Published: (2015-01-01)